Client News
FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region
11th March 2024
MIG Capital: MIG Capital leads €5 million Series A financing of animal healthcare company HawkCell to democratise MRI imaging
11th March 2024
Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024isease transgenic model to be presented at AD/PD™ 2024 Conference
8th March 2024
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023
6th March 2024
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
5th March 2024
CARBIOS Active, the enzymatic solution for 100% compostable PLA, added to FDA Inventory of Food Contact Substances
5th March 2024
Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve
29th February 2024
AATec Medical appoints Professor Dr. Claus Franz Vogelmeier to the Scientific Advisory Board
29th February 2024
CARBIOS and Landbell Group join forces to increase circularity of PET waste at first biorecycling plant
29th February 2024
Galimedix Therapeutics announces new pre-clinical data with GAL-201 in an Alzheimer’s disease transgenic model to be presented at AD/PD™ 2024 Conference
28th February 2024
There is no more content to load